InsiderClue
← All stocks

Edgewise Therapeutics, Inc.

EWTX Net buying
CIK 0001710072 #1406 in the set updated 18 Sep 2026
Bought (120 mo)
$79.04M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$46.45M
$506.73K on a plan · $38.09M straight out of an exercise
Sold at will
$7.86M
60 of 145 sales
Net
+$32.59M
+$71.18M against sales at will

By person

15 insiders · 172 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
ORBIMED ADVISORS LLC entity
Director
$26.74M (7)
—
+$26.74M
443,792
0.4086%
$19.26M
—
Thompson Peter A.
Director
$26.74M (7)
—
+$26.74M
443,792
0.4086%
$19.26M
—
Russell Alan J
Chief Scientific Officer
—
$23.50M (54) scheduled
−$23.50M
31,466
0.0290%
$1.37M
−88.5%
Novo Holdings A/S entity
10% owner
$15.00M (2)
—
+$15.00M
6,071,703
5.59%
$263.55M
—
Flynn James E
10% owner
$10.00M (1)
—
+$10.00M
3,933,137
3.62%
$170.72M
—
Donovan Joanne M.
CMO
—
$5.74M (17) scheduled
−$5.74M
8,625
0.0079%
$374.38K
−27.9%
Carruthers R Michael
Chief Financial Officer
—
$5.09M (9) scheduled
−$5.09M
86,162
0.0793%
$3.74M
+682.2%
MOORE JOHN R
General Counsel
—
$4.45M (35) scheduled
−$4.45M
17,697
0.0163%
$768.16K
+241.2%
Edris Badreddin
Director
—
$3.40M (5) scheduled
−$3.40M
19,820
0.0182%
$860.32K
0.0%
Derakhshan Behrad
Chief Business Officer
—
$2.05M (13) scheduled
−$2.05M
31,826
0.0293%
$1.38M
+221.9%
KOCH KEVIN
President and CEO
—
$1.34M (10) scheduled
−$1.34M
52,488
0.0483%
$2.28M
—
Semigran Marc
Chief Development Officer
—
$881.92K (2) scheduled
−$881.92K
6,716
0.0062%
$291.52K
0.0%
Fox Jonathan C
Director
$300.36K (2)
—
+$300.36K
24,833
0.0229%
$1.08M
—
ROOT JONATHAN D
Director
$250.00K (1)
—
+$250.00K
15,625
0.0144%
$678.23K
—
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
10% owner
—
—
—
681,812
0.6278%
$29.60M
—

Individual transactions

172
Insider
Date
Role
Action
Shares
Price
Amount
Donovan Joanne M.
13 Aug 2026
CMO
Sell
2,919
$43.41
$126.70K
KOCH KEVIN
12 Aug 2026
President and CEO
Sold after exercise
913
$44.33
$40.47K
KOCH KEVIN
12 Aug 2026
President and CEO
Sold after exercise
8,276
$43.66
$361.32K
KOCH KEVIN
12 Aug 2026
President and CEO
Sold after exercise
8,782
$43.64
$383.25K
Derakhshan Behrad
12 Aug 2026
Chief Business Officer
Sold after exercise
2,475
$43.70
$108.15K
Derakhshan Behrad
12 Aug 2026
Chief Business Officer
Sold after exercise
150
$44.44
$6.67K
Derakhshan Behrad
12 Aug 2026
Chief Business Officer
Sold after exercise
304
$44.50
$13.53K
Derakhshan Behrad
12 Aug 2026
Chief Business Officer
Sold after exercise
2,171
$43.79
$95.08K
MOORE JOHN R
12 Aug 2026
General Counsel
Sold after exercise
2,419
$43.80
$105.95K
MOORE JOHN R
12 Aug 2026
General Counsel
Sold after exercise
99
$44.50
$4.41K
MOORE JOHN R
12 Aug 2026
General Counsel
Sold after exercise
59
$44.41
$2.62K
MOORE JOHN R
12 Aug 2026
General Counsel
Sold after exercise
2,439
$43.81
$106.85K
Russell Alan J
12 Aug 2026
Chief Scientific Officer
Sold after exercise
390
$44.46
$17.34K
Russell Alan J
12 Aug 2026
Chief Scientific Officer
Sold after exercise
2,273
$43.68
$99.28K
Russell Alan J
12 Aug 2026
Chief Scientific Officer
Sold after exercise
3,238
$43.68
$141.43K
Donovan Joanne M.
12 Aug 2026
CMO
Sold after exercise
800
$44.52
$35.61K
Donovan Joanne M.
12 Aug 2026
CMO
Sold after exercise
104
$44.43
$4.62K
Donovan Joanne M.
12 Aug 2026
CMO
Sold after exercise
2,779
$43.71
$121.46K
Donovan Joanne M.
12 Aug 2026
CMO
Sold after exercise
2,839
$43.78
$124.30K
Russell Alan J
1 Jul 2026
Chief Scientific Officer
Sold after exercise
69,648
$39.41
$2.74M
Russell Alan J
1 Jul 2026
Chief Scientific Officer
Sold after exercise
130,352
$39.41
$5.14M
Donovan Joanne M.
5 May 2026
CMO
Sold after exercise
50,000
$38.57
$1.93M
Donovan Joanne M.
4 May 2026
CMO
Sell
5,230
$31.29
$163.66K
Donovan Joanne M.
1 Apr 2026
CMO
Sold after exercise
28,662
$32.31
$926.10K
Donovan Joanne M.
31 Mar 2026
CMO
Sold after exercise
21,338
$32.12
$685.31K
Donovan Joanne M.
27 Mar 2026
CMO
Sold on a plan
6,735
$30.98
$208.64K
Donovan Joanne M.
27 Mar 2026
CMO
Sold on a plan
9,623
$30.98
$298.10K
Edris Badreddin
21 Jan 2026
Director
Sold after exercise
66,477
$29.44
$1.96M
Edris Badreddin
21 Jan 2026
Director
Sold after exercise
10,463
$29.44
$308.03K
Edris Badreddin
21 Jan 2026
Director
Sold after exercise
7,605
$29.44
$223.89K
Edris Badreddin
21 Jan 2026
Director
Sold after exercise
17,236
$29.44
$507.43K
Edris Badreddin
21 Jan 2026
Director
Sold after exercise
13,690
$29.44
$403.03K
Russell Alan J
12 Nov 2025
Chief Scientific Officer
Sold after exercise
100,000
$21.12
$2.11M
Fox Jonathan C
11 Nov 2025
Director
Buy
10,700
$18.64
$199.40K
Russell Alan J
26 Aug 2025
Chief Scientific Officer
Sold after exercise
100,000
$14.60
$1.46M
Donovan Joanne M.
12 Aug 2025
CMO
Sold after exercise
2,862
$13.39
$38.33K
KOCH KEVIN
12 Aug 2025
President and CEO
Sold after exercise
7,972
$13.39
$106.76K
Russell Alan J
12 Aug 2025
Chief Scientific Officer
Sold after exercise
1,907
$13.39
$25.54K
Carruthers R Michael
12 Aug 2025
Chief Financial Officer
Sold after exercise
1,428
$13.39
$19.12K
Derakhshan Behrad
12 Aug 2025
Chief Business Officer
Sold after exercise
2,491
$13.39
$33.36K
MOORE JOHN R
12 Aug 2025
General Counsel
Sold after exercise
2,098
$13.39
$28.10K
Carruthers R Michael
2 May 2025
Chief Financial Officer
Sell
1,314
$16.45
$21.62K
Derakhshan Behrad
2 May 2025
Chief Business Officer
Sell
1,691
$16.45
$27.82K
Donovan Joanne M.
2 May 2025
CMO
Sell
5,187
$16.45
$85.35K
KOCH KEVIN
2 May 2025
President and CEO
Sell
4,276
$16.45
$70.36K
MOORE JOHN R
2 May 2025
General Counsel
Sell
1,930
$16.45
$31.76K
Russell Alan J
2 May 2025
Chief Scientific Officer
Sell
1,551
$16.45
$25.52K
ORBIMED ADVISORS LLC
3 Apr 2025
Director
Buy indirect
124,193
$20.13
$2.50M
ORBIMED ADVISORS LLC
3 Apr 2025
Director
Buy indirect
372,578
$20.13
$7.50M
Thompson Peter A.
3 Apr 2025
Director
Buy indirect
124,193
$20.13
$2.50M
Thompson Peter A.
3 Apr 2025
Director
Buy indirect
372,578
$20.13
$7.50M
KOCH KEVIN
7 Mar 2025
President and CEO
Sold after exercise
100
$30.00
$3.00K
Russell Alan J
7 Mar 2025
Chief Scientific Officer
Sold after exercise
200
$30.02
$6.00K
KOCH KEVIN
6 Feb 2025
President and CEO
Sold after exercise
900
$31.13
$28.02K
Russell Alan J
6 Feb 2025
Chief Scientific Officer
Sold after exercise
1,200
$30.13
$36.15K
Derakhshan Behrad
5 Feb 2025
Chief Business Officer
Sold after exercise
10,000
$30.03
$300.30K
KOCH KEVIN
5 Feb 2025
President and CEO
Sold after exercise
8,636
$30.03
$259.30K
Russell Alan J
5 Feb 2025
Chief Scientific Officer
Sold after exercise
8,015
$30.02
$240.62K
Donovan Joanne M.
28 Jan 2025
CMO
Sold after exercise
25,000
$27.63
$690.66K
Russell Alan J
30 Dec 2024
Chief Scientific Officer
Sold after exercise
100,000
$27.37
$2.74M
Semigran Marc
24 Dec 2024
Chief Development Officer
Sold after exercise
1,729
$30.08
$52.01K
Semigran Marc
24 Dec 2024
Chief Development Officer
Sold after exercise
27,980
$29.66
$829.91K
Carruthers R Michael
11 Oct 2024
Chief Financial Officer
Exercised, kept
70,000
$0.71
$49.70K
MOORE JOHN R
23 Sep 2024
General Counsel
Sold after exercise
20,922
$27.63
$578.06K
Carruthers R Michael
20 Sep 2024
Chief Financial Officer
Sold after exercise
50,000
$28.55
$1.43M
Carruthers R Michael
20 Sep 2024
Chief Financial Officer
Sold after exercise
24,960
$28.59
$713.51K
Carruthers R Michael
20 Sep 2024
Chief Financial Officer
Sold after exercise
4,064
$28.59
$116.17K
Carruthers R Michael
20 Sep 2024
Chief Financial Officer
Sold after exercise
46,068
$28.59
$1.32M
Derakhshan Behrad
20 Sep 2024
Chief Business Officer
Sold after exercise
42,068
$29.03
$1.22M
Donovan Joanne M.
20 Sep 2024
CMO
Sell
7,162
$28.29
$202.60K
MOORE JOHN R
20 Sep 2024
General Counsel
Sold after exercise
50,000
$28.37
$1.42M
Russell Alan J
20 Sep 2024
Chief Scientific Officer
Sold after exercise
815
$29.51
$24.05K
Russell Alan J
20 Sep 2024
Chief Scientific Officer
Sold after exercise
74,185
$28.25
$2.10M
KOCH KEVIN
2 May 2024
President and CEO
Sell
3,152
$18.91
$59.60K
Donovan Joanne M.
2 May 2024
CMO
Sell
3,682
$18.91
$69.63K
Russell Alan J
2 May 2024
Chief Scientific Officer
Sell
1,576
$18.91
$29.80K
Derakhshan Behrad
2 May 2024
Chief Business Officer
Sell
1,718
$18.91
$32.49K
Carruthers R Michael
2 May 2024
Chief Financial Officer
Sell
2,157
$18.91
$40.79K
MOORE JOHN R
2 May 2024
General Counsel
Sell
1,956
$18.91
$36.99K
Derakhshan Behrad
9 Feb 2024
Chief Business Officer
Sold after exercise
4,800
$20.04
$96.21K
MOORE JOHN R
9 Feb 2024
General Counsel
Sold after exercise
8,029
$20.01
$160.66K
Derakhshan Behrad
8 Feb 2024
Chief Business Officer
Sold after exercise
4,600
$20.01
$92.05K
MOORE JOHN R
8 Feb 2024
General Counsel
Sold after exercise
3,813
$20.01
$76.28K
Derakhshan Behrad
7 Feb 2024
Chief Business Officer
Sold after exercise
600
$20.00
$12.00K
MOORE JOHN R
7 Feb 2024
General Counsel
Sold after exercise
17,993
$20.00
$359.86K
ORBIMED ADVISORS LLC
23 Jan 2024
Director
Buy indirect
454,545
$11.00
$5.00M
Thompson Peter A.
23 Jan 2024
Director
Buy indirect
454,545
$11.00
$5.00M
Carruthers R Michael
23 Jan 2024
Chief Financial Officer
Sold after exercise
90,000
$15.78
$1.42M
MOORE JOHN R
27 Dec 2023
General Counsel
Sell
8,497
$10.50
$89.22K
Russell Alan J
26 Dec 2023
Chief Scientific Officer
Sell
172,585
$9.33
$1.61M
Fox Jonathan C
26 Dec 2023
Director
Buy
10,857
$9.30
$100.96K
Carruthers R Michael
22 Jun 2023
Chief Financial Officer
Exercised, kept
10,000
$0.71
$7.10K
KOCH KEVIN
2 May 2023
President and CEO
Sell
3,203
$8.90
$28.52K
Donovan Joanne M.
2 May 2023
CMO
Sell
3,254
$8.90
$28.98K
Russell Alan J
2 May 2023
Chief Scientific Officer
Sell
1,602
$8.90
$14.27K
Carruthers R Michael
2 May 2023
Chief Financial Officer
Sell
1,336
$8.90
$11.90K
MOORE JOHN R
2 May 2023
General Counsel
Sell
1,897
$8.90
$16.89K
Derakhshan Behrad
2 May 2023
Chief Business Officer
Sell
1,747
$8.90
$15.56K
MOORE JOHN R
3 Oct 2022
General Counsel
Sold after exercise
4,730
$9.76
$46.15K
ORBIMED ADVISORS LLC
16 Sep 2022
Director
Buy indirect
484,496
$10.32
$5.00M
Thompson Peter A.
16 Sep 2022
Director
Buy indirect
484,496
$10.32
$5.00M
Novo Holdings A/S
14 Sep 2022
10% owner
Buy
484,496
$10.32
$5.00M
MOORE JOHN R
6 Sep 2022
General Counsel
Sold after exercise
2,351
$10.99
$25.84K
MOORE JOHN R
6 Sep 2022
General Counsel
Sold after exercise
2,379
$10.83
$25.76K
MOORE JOHN R
3 Aug 2022
General Counsel
Sold after exercise
9,232
$9.31
$85.92K
MOORE JOHN R
6 Jul 2022
General Counsel
Sold after exercise
1,046
$8.54
$8.93K
MOORE JOHN R
5 Jul 2022
General Counsel
Sold after exercise
8,186
$8.35
$68.33K
MOORE JOHN R
21 Jun 2022
General Counsel
Sold after exercise
31,078
$7.29
$226.70K
MOORE JOHN R
17 Jun 2022
General Counsel
Sold after exercise
22,127
$6.62
$146.43K
MOORE JOHN R
16 Jun 2022
General Counsel
Sold after exercise
14,722
$6.17
$90.81K
MOORE JOHN R
15 Jun 2022
General Counsel
Sold after exercise
18,075
$6.11
$110.45K
MOORE JOHN R
15 Jun 2022
General Counsel
Sold after exercise
585
$6.11
$3.57K
MOORE JOHN R
14 Jun 2022
General Counsel
Sold after exercise
3,628
$6.02
$21.85K
MOORE JOHN R
13 Jun 2022
General Counsel
Sold after exercise
4,093
$6.01
$24.58K
MOORE JOHN R
10 Jun 2022
General Counsel
Sold after exercise
7,125
$6.05
$43.12K
MOORE JOHN R
9 Jun 2022
General Counsel
Sold after exercise
7,615
$6.49
$49.40K
MOORE JOHN R
8 Jun 2022
General Counsel
Sold after exercise
12,566
$6.63
$83.36K
MOORE JOHN R
7 Jun 2022
General Counsel
Sold after exercise
17,150
$6.61
$113.28K
MOORE JOHN R
7 Jun 2022
General Counsel
Sold after exercise
973
$6.61
$6.43K
MOORE JOHN R
6 Jun 2022
General Counsel
Sold after exercise
13,934
$6.03
$84.08K
MOORE JOHN R
3 Jun 2022
General Counsel
Sold after exercise
15,230
$6.05
$92.20K
Carruthers R Michael
23 May 2022
Chief Financial Officer
Exercised, kept
9,000
$0.71
$6.39K
Thompson Peter A.
18 May 2022
Director
Buy indirect
138,000
$7.21
$994.98K
ORBIMED ADVISORS LLC
18 May 2022
Director
Buy indirect
138,000
$7.21
$994.98K
MOORE JOHN R
16 May 2022
General Counsel
Sell
10,800
$7.42
$80.15K
MOORE JOHN R
21 Jan 2022
General Counsel
Exercised, kept
5,400
$0.71
$3.83K
MOORE JOHN R
28 Dec 2021
General Counsel
Exercised, kept
5,400
$0.71
$3.83K
Russell Alan J
30 Nov 2021
Chief Scientific Officer
Exercised, kept
25,000
$0.45
$11.25K
Russell Alan J
30 Nov 2021
Chief Scientific Officer
Exercised, kept
147,585
$0.18
$26.57K
Russell Alan J
15 Nov 2021
Chief Scientific Officer
Sell
38
$19.61
$745.18
Russell Alan J
15 Nov 2021
Chief Scientific Officer
Sell
441
$19.07
$8.41K
Russell Alan J
12 Nov 2021
Chief Scientific Officer
Sell
8,562
$19.51
$167.07K
Russell Alan J
11 Nov 2021
Chief Scientific Officer
Sell
3,681
$20.43
$75.20K
Russell Alan J
11 Nov 2021
Chief Scientific Officer
Sell
15,595
$19.82
$309.04K
Russell Alan J
10 Nov 2021
Chief Scientific Officer
Sell
580
$20.21
$11.72K
Russell Alan J
10 Nov 2021
Chief Scientific Officer
Sell
11,746
$19.70
$231.45K
Russell Alan J
9 Nov 2021
Chief Scientific Officer
Sell
12,712
$20.30
$258.03K
Russell Alan J
9 Nov 2021
Chief Scientific Officer
Sell
16,864
$19.94
$336.27K
Russell Alan J
8 Nov 2021
Chief Scientific Officer
Sell
9,017
$20.16
$181.82K
Russell Alan J
5 Nov 2021
Chief Scientific Officer
Sell
13,036
$19.62
$255.78K
Russell Alan J
5 Nov 2021
Chief Scientific Officer
Sell
6
$20.70
$124.20
Russell Alan J
4 Nov 2021
Chief Scientific Officer
Sell
7,392
$19.76
$146.09K
Russell Alan J
3 Nov 2021
Chief Scientific Officer
Sell
1,119
$19.42
$21.73K
Russell Alan J
3 Nov 2021
Chief Scientific Officer
Sell
4,243
$18.84
$79.94K
Russell Alan J
3 Nov 2021
Chief Scientific Officer
Sell
20,822
$17.98
$374.43K
Russell Alan J
2 Nov 2021
Chief Scientific Officer
Sell
17,519
$17.43
$305.36K
Russell Alan J
1 Nov 2021
Chief Scientific Officer
Sell
469
$18.02
$8.45K
Russell Alan J
15 Oct 2021
Chief Scientific Officer
Sell
126
$18.00
$2.27K
Russell Alan J
15 Oct 2021
Chief Scientific Officer
Sell
1,307
$18.13
$23.70K
Russell Alan J
14 Oct 2021
Chief Scientific Officer
Sell
5,749
$18.18
$104.52K
Russell Alan J
11 Oct 2021
Chief Scientific Officer
Sell
1,270
$18.02
$22.89K
Russell Alan J
8 Oct 2021
Chief Scientific Officer
Sell
5,902
$18.15
$107.12K
Russell Alan J
7 Oct 2021
Chief Scientific Officer
Sell
13,018
$18.56
$241.61K
Russell Alan J
6 Oct 2021
Chief Scientific Officer
Sell
2,108
$18.03
$38.01K
Russell Alan J
5 Oct 2021
Chief Scientific Officer
Sell
5,404
$18.26
$98.68K
Russell Alan J
4 Oct 2021
Chief Scientific Officer
Sell
100
$18.00
$1.80K
Russell Alan J
1 Oct 2021
Chief Scientific Officer
Sell
274
$18.00
$4.93K
Russell Alan J
29 Sep 2021
Chief Scientific Officer
Sell
618
$17.47
$10.80K
Russell Alan J
29 Sep 2021
Chief Scientific Officer
Sell
11,226
$16.83
$188.93K
Russell Alan J
28 Sep 2021
Chief Scientific Officer
Sell
14,610
$17.30
$252.75K
Russell Alan J
27 Sep 2021
Chief Scientific Officer
Sell
17
$18.48
$314.16
Russell Alan J
27 Sep 2021
Chief Scientific Officer
Sell
11,594
$17.98
$208.46K
Russell Alan J
24 Sep 2021
Chief Scientific Officer
Sell
20,100
$18.16
$365.02K
Russell Alan J
23 Sep 2021
Chief Scientific Officer
Sell
5,072
$19.42
$98.50K
Russell Alan J
23 Sep 2021
Chief Scientific Officer
Sell
21,763
$18.34
$399.13K
Flynn James E
30 Mar 2021
10% owner
Buy indirect
625,000
$16.00
$10.00M
Novo Holdings A/S
30 Mar 2021
10% owner
Buy
625,000
$16.00
$10.00M
ORBIMED ADVISORS LLC
30 Mar 2021
Director
Buy indirect
312,500
$16.00
$5.00M
ORBIMED ADVISORS LLC
30 Mar 2021
Director
Buy indirect
46,875
$16.00
$750.00K
Thompson Peter A.
30 Mar 2021
Director
Buy indirect
312,500
$16.00
$5.00M
Thompson Peter A.
30 Mar 2021
Director
Buy indirect
46,875
$16.00
$750.00K
ROOT JONATHAN D
30 Mar 2021
Director
Buy
15,625
$16.00
$250.00K

What was left out

Form 4 filings counted 173
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 6
Sales on a Rule 10b5-1 plan 2
Sales straight out of an exercise 83
Sales at will 60
Transactions with no price 0
Shares from compensation/vesting 43,853,493
Sales filed before the plan box existed 37
History held since 30 Mar 2021